European Stroke Conference

Time:May 6-9,2014Venue:Nice,France Email:hennerici@eurostroke.eu Website:www.eurostroke.eu,www.eurostroke.org Deadline for abstract submission:January 12,2014The European Stroke Conference(ESC)was founded in 1990 by J.Bogousslavsky(Switzerland)and M.G.Hennerici(Germany).The first meeting was held in Düsseldorf and was attended by about 500 people and proved to be a great success.At that time only the North American conference existed for clinical researchers and basic scientists to present data from stroke     

ⅩⅩⅣ European Stroke Conference

Time：May 12-15,2015Venue：Vienna,Austria Email：m.g.hennerici@eurostroke.eu Website：http：//www.eurostroke.eu/On behalf of the European Stroke Conference（ESC）Programme Committee,it is my pleasure to invite you all to theⅩⅩⅣESC in Vienna,Austria,where the Conference first met at the turn of the century in 2000.We invite all of you to contribute to our annual meeting and acknowledge your support through submission of proposals for teaching courses,mini and educational symposia,lectures as well as new topics.We also invite you to submit abstracts for oral and poster sessions on our homepage www.eurostroke.     

X X IV European Stroke Conference

On behalf of the European Stroke Conference （ESC） Programme Committee it is my pleasure to invite you all to the X X IV ESC in Vienna, Austria, where the Conference first met at the turn of the century in 2000. We invite all of you to contribute to our annual meeting and acknowledge your support through submission of proposals for teaching courses, mini and educational symposia, lectures as well as new topics.     

Ⅹ Ⅹ Ⅳ European Stroke Conference

<正>Time:May 12-15,2015Venue:Vienna,AustriaEmail:m.g.hennerici@eurostroke.euWebsite:http://www.eurostroke.eu/On behalf of the European Stroke Conference(ESC)Programme Committee it is my pleasure to invite you all to theⅩⅩⅣESC in Vienna,Austria,where the Conference first met at the turn of the century in 2000.We invite all of you to contribute toour annual meeting and acknowledge your support through submission of proposals for teaching courses,mini and educationalsymposia,lectures as well as new topics.     

Ⅹ Ⅹ Ⅳ European Stroke Conference

<正>Time:May 12-15,2015Venue:Vienna,AustriaEmail:m.g.hennerici@eurostroke.euWebsite:http://www.eurostroke.eu/On behalf of the European Stroke Conference(ESC)Programme Committee it is my pleasure to invite you all to theⅩⅩⅣ     

Tiantan International Stroke Conference (TISC) 2006:A Milestone for the Advances of Stroke in China

Tiantan International Stroke Conference (TISC) 2006 was held on June 16-18,2006 in Beijing China.The International Health Exchange and Cooperation Center of Ministry of Health,International Chinese Stroke Federation, Neurology Research Institute of Chinese Academy of Medical Science,National Stroke Prevention and Research Office,     

Stroke：颅内支架3年再狭窄率

正支架治疗对比积极药物治疗预防颅内动脉狭窄卒中复发试验(Stenting and Aggressive MedicalManagementforPreventing Recurrent Stroke in Intracranial Stenosis,SAMMPRIS)最终因为颅内支架组30 d卒中和     

Stroke：小脑浅表微出血的临床意义

原发性小脑出血的病因通常被认为是高血压小血管病(small vessel disease,SVD),但也有报道提示也可能与脑淀粉样血管病(cerebral amyloid angiopathy,CAA)有关。鉴别CAA和高血压SVD主要依据幕上区域和脑干的出血影像学标志,特别是微出血。按照病理学确认的Boston标准,脑叶出血和局限于脑叶的多发脑微出血最有可能为CAA,局限于深部的出血或合并幕上脑叶和深部出血(混合-脑出血/微出血)者可能为高血压SVD。有报道显示,CAA患者小脑微出血的可能性显著高于混合和深部脑出血患者。     

Preparing for a “Pediatric Stroke Alert”

BackgroundChildhood arterial ischemic stroke is an important cause of morbidity and mortality in children. Hyperacute treatment strategies remain controversial and challenging, especially in the setting of increasingly proven medical and endovascular options in adults. Although national and international pediatric guidelines have given initial direction about acute therapy and management, pediatric centers have traditionally lacked the infrastructure to triage, diagnose, and treat childhood arterial ischemic stroke quickly.MethodsIn the past 10 years, researchers in the International Pediatric Stroke Study and Thrombolysis in Pediatric Stroke study have initiated early strategies for establishing pediatric specific stroke alerts.ResultsWe review the rationale, process and components necessary for establishing a pediatric stroke alert.ConclusionDevelopment of pediatric stroke protocols and pathways, with evidence-based acute management strategies and supportive care where possible, facilitates the evaluation, management, and treatment of an acute pediatric stroke.     

Stroke trials: what have we learned?

We reviewed the recent, major, therapeutic trials of intravenous thrombolytic therapy and ancrod for ischemic stroke. Randomized, controlled studies of acute ischemic stroke treatment were reviewed. Several post-FDA approval intravenous tPA studies were reviewed to understand the experience of this medication in practice. STAT trial was the major study using ancrod. Of multiple intravenous thrombolytic studies, the NINDS study of intravenous tPA was the only study to demonstrate a significantly higher percentage of patients with complete recovery or minimal deficit at three months. Studies in communities utilizing intravenous tPA for stroke illustrate the need for close adherence to the NINDS study protocol or else the risk of tPA use may exceed the benefits.     

Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group.

BACKGROUND AND PURPOSE: The National Institutes of Health Stroke Scale (NIHSS) is a valid, reproducible scale that measures neurological deficit. Of 42 possible points, 7 points are directly related to measurement of language compared with only 2 points related to neglect. METHODS: We examined the placebo arm of the NINDS t-PA stroke trial to test the hypothesis that the total volume of cerebral infarction in patients with right hemisphere strokes would be greater than the volume of cerebral infarction in patients with left hemisphere strokes who have similar NIHSS scores. The volume of stroke was determined by computerized image analysis of CT films and CT images stored on computer tape and optical disks. Cube-root transformation of lesion volume was performed for each CT. Transformed lesion volume was analyzed in a logistic regression model to predict volume of stroke by NIHSS score for each hemisphere. Spearman rank correlation was used to determine the relation between the NIHSS score and lesion volume. RESULTS: The volume for right hemisphere stroke was statistically greater than the volume for left hemisphere strokes, adjusting for the baseline NIHSS (P<0. 001). For each 5-point category of the NIHSS score <20, the median volume of right hemisphere strokes was approximately double the median volume of left hemisphere strokes. For example, for patients with a left hemisphere stroke and a 24-hour NIHSS score of 16 to 20, the median volume of cerebral infarction was 48 mL (interquartile range 14 to 111 mL) as compared with 133 mL (interquartile range 81 to 208 mL) for patients with a right hemisphere stroke (P<0.001). The median volume of a right hemisphere stroke was roughly equal to the median volume of a left hemisphere stroke in the next highest 5-point category of the NIHSS. The Spearman rank correlation between the 24-hour NIHSS score and 3-month lesion volume was 0.72 for patients with left hemisphere stroke and 0.71 for patients with right hemisphere stroke. CONCLUSIONS: For a given NIHSS score, the median volume of right hemisphere strokes is consistently larger than the median volume of left hemisphere strokes. The clinical implications of our finding need further exploration.     

Stroke杂志视频讲座植入本刊视频栏目

美国心脏病协会Stroke杂志网站的视频栏目——Webinar是Stroke杂志新视频栏目，以在线讲座和网络讨论会的形式，汇聚国际脑血管病领域最新研究进展和世界权威专家的视点，特别是临床经验的交流、焦点问题的讨论对临床实践具有十分重要的指导意义，吸引着全球医生的关注。     

Stroke：患者进城，还是医生下乡？

正血管内治疗是急性缺血性卒中治疗的有效方法,但是受到时间窗的限制。在缺血的情况下神经组织迅速死亡,因此缩短治疗时间是卒中治疗的主要目标。在2015年以前,静脉溶栓是治疗急性缺血性卒中唯一有效的手段。对于需要静脉重组组织型纤溶酶原激活物(recombinant tissue plasminogen activator,rt-PA)溶栓的患者,两种最常用的转运模式为治疗-转